Whalegun
Home

Ultragenyx Pharmaceutical RARE spent $30K on lobbying in Q2 2024 · Health Issues, Budget and 1 more issue

Trade details

Type
Lobbying report
Amount
$30,000
Quarter
Q2 2024
Stock
Ultragenyx Pharmaceutical RARE
Client
Ultragenyx Pharmaceutical
Reported
24/07/22

Down 86.4% from last quarter

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 24/05/31~24/07/30

Ultragenyx Pharmaceutical's other lobbying reports

Ultragenyx Pharmaceutical RARE spent $30K on lobbying in Q2 2024 · Health Issues, Budget and 1 more issue | Whalegun